Info Center

• Jul 12, 2010 - ZymoGenetics to Host Conference Call and Webcast on August 3, 2010 to Discuss Second Quarter 2010 Financial Results
• Jun 18, 2010 - Lars Fruergaard Jørgensen Joins the ZymoGenetics Board of Directors
• Jun 15, 2010 - ZymoGenetics to Webcast Presentation at the Piper Jaffray Europe Conference
• Jun 5, 2010 - ZymoGenetics Reports Positive IL-21 Phase 2 Results in Metastatic Melanoma
• Jun 2, 2010 - ZymoGenetics Initiates PEG-Interferon lambda Phase 2b Clinical Trial in Hepatitis C in Collaboration with Bristol-Myers Squibb
• May 20, 2010 - ZymoGenetics Announces Upcoming Presentation of Positive IL-21 Phase 2 Results in Metastatic Melanoma at ASCO Meeting
• May 5, 2010 - ZymoGenetics to Webcast Presentation at the Bank of America Merrill Lynch Health Care Conference
• May 4, 2010 - ZymoGenetics Reports First Quarter 2010 Financial Results
• Apr 16, 2010 - ZymoGenetics to Host Conference Call and Webcast on May 4, 2010 to Discuss Q1 2010 Financial Results

• News Archive »
  
  

• 2009 Annual Report
• Full Year 2009
• 1st Quarter 2010
• Information Request
• Email Subscription

Stock Symbol: ZGEN
Exchange: NASDAQ GM
Quote: As of Jul 30, 2010

Minimum 20 minutes delayed

Last: $4.09
Previous Close: $3.94
Change: $0.15
% Change: 3.807%

Day Vol: 151,648
Day Open: $3.87
Day High: $4.11
Day Low: $3.84

Avg Vol: 327,000
Mkt Cap (MM): $250
52 Wk High: $7.31
52 Wk Low: $3.70

• Advanced Stock Info »
  
  

• Barclays Capital
  Jim Birchenough
• Biotech Stock Research
  David Miller
• Cross Current Research
  Alex To
• Leerink Swann
  Howard Liang
• McAdams Wright Ragen
  Paul Latta
• Oppenheimer
  Brian Abrahams
• Piper Jaffray
  Edward Tenthoff
• UBS
  Jeff Elliott
• Wedbush Pac Grow Life Sciences
  Gregory Wade
• William Blair and Company
  John Sonnier